BIT 5.26% 2.0¢ biotron limited

No data, no new trials and no mice to the sword!, page-236

  1. 19,272 Posts.
    lightbulb Created with Sketch. 6368
    And what commercial outcome has come from any of these trials? I am fully committed to making a profit on every company I invested in, but unfortunately I often fail.

    While we would need to hear from BIT about why they are at BIO 2019, it is not the place to attend if you are in serious negotiations with a pharma company over a large deal to fund a phase 3 trial. It is the place to go to look for a partner or just network.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.